These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Patterson TF, Boucher HW, Herbrecht R, Denning DW, Lortholary O, Ribaud P, Rubin RH, Wingard JR, DePauw B, Schlamm HT, Troke P, Bennett JE, European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG), Pfizer Global Aspergillus Study Group. Clin Infect Dis; 2005 Nov 15; 41(10):1448-52. PubMed ID: 16231256 [Abstract] [Full Text] [Related]
10. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Sen P, Gopal L, Sen PR. Retina; 2006 Oct 15; 26(8):935-9. PubMed ID: 17031296 [Abstract] [Full Text] [Related]
12. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Sambatakou H, Dupont B, Lode H, Denning DW. Am J Med; 2006 Jun 15; 119(6):527.e17-24. PubMed ID: 16750972 [Abstract] [Full Text] [Related]
13. Management of mycoses in surgical patients -- review of the literature. Holzheimer RG, Dralle H. Eur J Med Res; 2002 May 31; 7(5):200-26. PubMed ID: 12069912 [Abstract] [Full Text] [Related]